The Economic Times

As weight-loss drug users turn to dietary supplements, doctors, regulators raise flags

The growing use of GLP-1 weight-loss drugs such as Ozempic and Wegovy is driving demand for dietary supplements in the US, as users seek to manage side effects including nausea, fatigue and constipation. Supplement sales exceeded $74 billion in 2025, while TikTok Shop generated more than $1 billion in supplement sales.